Sleep apnea study aims to predict heart trouble with better breathing metrics

NCT ID NCT07427589

Recruiting now Knowledge-focused Sponsor: University Hospital, Antwerp Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study will test new methods to measure how sleep apnea affects the heart. Researchers will follow 270 adults with moderate to severe sleep apnea who use CPAP, mouth devices, or nerve stimulation. The goal is to see if these new metrics can better predict heart problems than current tools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous positive airway pressure (CPAP), mandibular advancement device (MAD), hypoglossal nerve stimulation
What this could lead to: If successful, this could lead to better tools for predicting heart problems in people with sleep apnea, helping doctors choose the most effective treatment.
What could go wrong: This is an early-stage observational study, not a treatment trial. The new metrics may not prove useful in everyday practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR (CV) RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR (CV) RISK OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Locations

Antwerp University Hospital
RECRUITING

Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.